pyrogallol has been researched along with Lung Neoplasms in 9 studies
benzenetriol : A triol in which three hydroxy groups are substituted onto a benzene ring.
Lung Neoplasms: Tumors or cancer of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
"Pyrogallol (PG) is a polyphenol compound and has been known to be an O(2)(." | 1.35 | Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest. ( Han, YH; Kim, SH; Kim, SZ; Park, WH, 2008) |
"Pyrogallol (PG) is a polyphenol compound and is known to be an O2." | 1.35 | Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion. ( Han, YH; Kim, SH; Kim, SZ; Park, WH, 2008) |
"Pyrogallol (PG) is a polyphenol compound and a known O2- generator." | 1.35 | Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis. ( Han, YH; Kim, SH; Kim, SZ; Park, WH, 2009) |
"Treatment with pyrogallol also reduced the intracellular GSH content." | 1.35 | Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. ( Han, YH; Kim, SH; Kim, SZ; Park, WH, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
de Miranda, LBL | 1 |
Lima, K | 1 |
Coelho-Silva, JL | 1 |
Traina, F | 1 |
Kobayashi, SS | 1 |
Machado-Neto, JA | 1 |
Ishii, H | 1 |
Vodnala, SK | 1 |
Achyut, BR | 1 |
So, JY | 1 |
Hollander, MC | 1 |
Greten, TF | 1 |
Lal, A | 1 |
Yang, L | 1 |
Han, YH | 5 |
Kim, SZ | 4 |
Kim, SH | 4 |
Park, WH | 5 |
Yang, CJ | 1 |
Wang, CS | 1 |
Hung, JY | 1 |
Huang, HW | 1 |
Chia, YC | 1 |
Wang, PH | 1 |
Weng, CF | 1 |
Huang, MS | 1 |
Moon, HJ | 1 |
You, BR | 1 |
Zheng, GQ | 1 |
Kenney, PM | 1 |
Zhang, J | 1 |
Lam, LK | 1 |
9 other studies available for pyrogallol and Lung Neoplasms
Article | Year |
---|---|
NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; MAP Kina | 2022 |
miR-130a and miR-145 reprogram Gr-1
Topics: Animals; Antineoplastic Agents; CD11b Antigen; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Drug Ev | 2018 |
Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest.
Topics: Adenocarcinoma; Antioxidants; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinases; Cyc | 2008 |
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
Topics: Adenocarcinoma; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation; Cyste | 2008 |
Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survi | 2009 |
Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Pro | 2009 |
The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Topics: Annexin A5; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Glutathione; Humans; Indicators | 2010 |
Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels.
Topics: Adenocarcinoma; Analysis of Variance; Antioxidants; Apoptosis; Blotting, Western; Catalase; Cyclic N | 2008 |
Inhibition of benzo[a]pyrene-induced tumorigenesis by myristicin, a volatile aroma constituent of parsley leaf oil.
Topics: Allylbenzene Derivatives; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Benzyl Compounds; Dioxol | 1992 |